FDA Approved: CAPLYTA — Original Application (Intra-Cellular Therapies, Inc)

View source ↗

Summary

The FDA approved CAPLYTA (lumateperone) in its original application by Intra-Cellular Therapies for the treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Caplyta (lumateperone)

Snippet

ORIG AP for CAPLYTA (LUMATEPERONE)